Suchergebnisse - "Dondorp, Arjen M"

PubPharm (25)

1

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

enthalten in: EBioMedicine | 2023

von Mukaka, M. | Onyamboko, M. | Olupot-Olupot, P. | +30

2

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

enthalten in: Malaria journal | 2023

von Rahmasari, F. | Asih, P. | Rozi, I. | +12

3

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo : a randomised, double-blind, placebo-controlled, non-inferiority trial

enthalten in: The Lancet. Infectious diseases | 2023

von Taylor, W. | Olupot-Olupot, P. | Onyamboko, M. | +24

CommentIn: Lancet Infect Dis. 2023 Apr;23(4):388-390. - PMID 36462525

4

Mass drug administration for the acceleration of malaria elimination in a region of Myanmar with artemisinin-resistant falciparum malaria : a cluster-randomised trial

enthalten in: The Lancet. Infectious diseases | 2021

von McLean, A. | Indrasuta, C. | Khant, Z. | +18

CommentIn: Lancet Infect Dis. 2021 Nov;21(11):1480-1481. - PMID 34147153

5

The risk of Plasmodium vivax parasitaemia after P. falciparum malaria : An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network

enthalten in: PLoS medicine | 2020

von Hossain, M. | Commons, R. | Douglas, N. | +45

6

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria : a multicentre, open-label, randomised clinical trial

enthalten in: Lancet (London, England) | 2020

von van der Pluijm, R. | Tripura, R. | Hoglund, R. | +142

CommentIn: Lancet. 2020 Apr 25;395(10233):1316-1317. - PMID 32171077

7

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax : Findings from randomised controlled trials

enthalten in: PloS one | 2020

von Phommasone, K. | van Leth, F. | Peto, T. | +35

8

Combining antimalarial drugs and vaccine for malaria elimination campaigns : a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

enthalten in: Human vaccines & immunotherapeutics | 2020

von von Seidlein, L. | Hanboonkunupakarn, B. | Jittamala, P. | +19

9

The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections : a randomized, controlled trial in Lao PDR

enthalten in: Malaria journal | 2020

von Phommasone, K. | van Leth, F. | Imwong, M. | +16

ErratumIn: Malar J. 2020 Jan 21;19(1):32. - PMID 31964377

10

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence : A systematic review and individual patient data meta-analysis

enthalten in: PLoS medicine | 2019

von Commons, R. | Simpson, J. | Thriemer, K. | +35